Relation Between Postprandial Lipogram and Coronary Artery Disease Severity
Launched by ASSIUT UNIVERSITY · Jun 1, 2017
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
Coronary artery disease (CAD) is usually used to refer to the pathological problem affecting the coronary arteries (usually atherosclerosis) that leads to Coronary Heart disease (CHD) which includes the diagnoses of angina pectoris, MI and silent myocardial ischemia.
Despite the mortality for this condition has gradually declined over the last decades in western countries, it still causes about one-third of all deaths in people older than 35 years.
Dyslipidemia is very important risk factors of atherosclerosis that is one of the causes leading to cardiovascular disease.
Despite managemen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with documented coronary artery disease and stable for 3 months with no secondary dyslipidemia as hypothyroidism and renal impairment
- Exclusion Criteria:
- • patients with acute coronary syndrome or any cause of Secondary dyslipidemia
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Assiut, , Egypt
Patients applied
Trial Officials
Hosam Elaraby, MD
Study Chair
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials